Latest Artificial Intelligence News

Prime Financial Group Ltd reported robust FY25 results, driven by a 21% revenue increase and key acquisitions that expanded its client base and funds under management. The company’s strategic focus on M&A, technology, and mid-market opportunities sets the stage for ambitious future growth.

Prime Financial Group delivered a robust FY25 performance, with revenue climbing 21% and Funds Under Management soaring 58% following a key acquisition. The company sets sights on doubling revenue within five years.

Prime Financial Group Ltd has reported a robust 21% increase in revenue to $49.4 million for FY25, alongside a 62% jump in net profit after tax. The company’s strategic acquisition of Lincoln Indicators Pty Ltd bolsters its wealth management capabilities and client base.

Centrepoint Alliance has reported a robust FY25 with 13% revenue growth and a 30% increase in profit before tax, driven by organic adviser expansion, strategic acquisitions, and pioneering technology investments including AI and cybersecurity.

Beforepay Group Limited reported a strong FY25 with a 29% increase in net transaction margin and 14% revenue growth, driven by expanding user numbers and advances. The company continues to leverage AI-driven risk management while maintaining its ethical lending model.

Beforepay Group Limited reported a robust 74% jump in net profit for FY25, driven by stronger advance volumes, improved credit quality, and expanding user base. Its AI-powered lending division, Carrington Labs, accelerated growth with new clients and strategic partnerships.

Centrepoint Alliance has reported a robust FY25 financial performance, surpassing earnings guidance with a 16% rise in EBITDA and a 30% jump in pre-tax profits. The company also declared a 1.75 cent final dividend and advanced its technology and advisory services.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Symal Group has outperformed its FY25 earnings forecasts, driven by strong project margins and strategic acquisitions, setting a robust foundation for FY26 growth.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

Regis Healthcare delivered a robust FY25 performance with a 14.5% revenue increase and a dramatic turnaround to a $49 million net profit. The company is advancing growth through acquisitions and greenfield developments, positioning itself strongly ahead of upcoming sector reforms.